NCT01463384View on ClinicalTrials.gov

Minocycline in Patients With Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Mild Cognitive ImpairmentAlzheimer's Disease
Interventions
DRUG

Minocycline

50mg, twice daily for 6 months.

Trial Locations (1)

91105

Huntington Medical Research Institutes, Pasadena

Sponsors
All Listed Sponsors
lead

Huntington Medical Research Institutes

OTHER